A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Outpatient, Parallel-Group Study to Assess the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures
Latest Information Update: 18 Sep 2024
At a glance
- Drugs Alprazolam (Primary)
- Indications Seizures
- Focus Registrational; Therapeutic Use
- Sponsors UCB Biopharma
- 30 Aug 2024 Planned End Date changed from 17 Apr 2024 to 6 Apr 2026.
- 30 Aug 2024 Planned primary completion date changed from 17 Apr 2024 to 6 Apr 2026.
- 16 May 2023 Planned End Date changed from 17 Jul 2023 to 17 Apr 2024.